Bio-Rad Laboratories, Inc. (BIO) vs 23andMe Holding Co. (ME)
BIO leads on 6 of 9 compared metrics.
A side-by-side comparison of Bio-Rad Laboratories, Inc. and 23andMe Holding Co. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — BIO vs ME
growth of $100 · last 5yBIO -52.3%ME -99.7%BIO compounded faster
Log scale — wide-divergence pair
BIO ME
BIO vs ME: by the numbers
- •BIO is the larger company ($7.73B vs $15M market cap).
- •BIO is profitable (6.52% net margin) while ME runs a net loss (-134.54%).
- •BIO grew revenue faster over the past five years (-0.84% vs -9.07% CAGR).
Which is better, BIO or ME?
Metric tally: BIO 6 · ME 3It depends on what you're optimizing for:
GrowthBIO(faster 5Y revenue CAGR)
QualityBIO(higher ROIC)
Valuation
| Metric | BIO | ME |
|---|---|---|
| P/E ratio | 47.11 | — |
| Forward P/E | 28.69 | — |
| P/S ratio | 2.98 | 0.10● |
| P/B ratio | 1.13 | 0.51● |
| EV / EBITDA | 20.01 | — |
| FCF yield | 4.63% | — |
Profitability
| Metric | BIO | ME |
|---|---|---|
| Gross margin | 51.87% | 53.33%● |
| Operating margin | 9.25%● | -114.00% |
| Net margin | 6.52%● | -134.54% |
| ROE | 2.46%● | -721.75% |
| ROIC | 2.04%● | -553.10% |
Growth (annualized)
| Metric | BIO | ME |
|---|---|---|
| Revenue CAGR (5Y) | -0.84%● | -9.07% |
| EPS CAGR (5Y) | -26.27% | — |
| FCF CAGR (5Y) | -7.57% | — |
| Total return CAGR (5Y) | -13.82%● | -68.93% |
Frequently asked
- Which is better, BIO or ME?
- It depends on your goal. growth: BIO (faster 5Y revenue CAGR); quality: BIO (higher ROIC). Across all compared metrics, BIO leads 6 to 3.
- Which has grown faster, BIO or ME?
- Over the past five years, BIO grew revenue faster — BIO at a -0.84% CAGR versus ME at -9.07%.
- Is BIO or ME more profitable?
- BIO runs the higher net margin — BIO at 6.52% versus ME at -134.54%.
- Which has been the better investment, BIO or ME?
- Over the past 5-year, BIO delivered the higher annualized total return — BIO at 6.91% versus ME at -68.93%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Bio-Rad Laboratories P/E ratio23andMe P/E ratioBio-Rad Laboratories dividend yield23andMe dividend yieldBio-Rad Laboratories ROE23andMe ROEBio-Rad Laboratories operating margin23andMe operating marginBio-Rad Laboratories revenue growth23andMe revenue growthBio-Rad Laboratories free cash flow23andMe free cash flow
Bio-Rad Laboratories & 23andMe appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.